Bahasa

   Home      Contact
› News Archive
› Events Archive

EVENTS
12th APLAR Tentative Scientific Program
Wednesday, 2nd August
Rooms MR 305
COPCORD Stage I Symposium 14.00-15.00
Chairpersons John Darmawan & Syed Atiqul Haq

COPCORD Taiwan, China
Chung-tei Chou

COPCORD, Iran
Fereydoun Davatchi

COPCORD China
Qingyu Zeng

COPCORD Egypt
Ahmad Abdel Nasser

12th APLAR Tentative Scientific Program
Wednesday, 2nd August
Rooms MR 305
COPCORD Stage I Symposium 15.30-16.30
Chairpersons John Darmawan & Syed Atiqul Haq

COPCORD India
Arvind Chopra

COPCORD Philippnes
Leonila Dans

COPCORD Bangladesh I
Syed Atiqul Haq

COPCORD Bangladesh II
Nazrul Islam

12th APLAR Tentative Scientific Program
Thursday, 3rd August
Rooms MR 305
COPCORD Policy Making Meeting 11.00-12.30
Chairpersons J J Rasker & Arvind Chopra

COPCORD Achievements and Shortcomings 1980-2005
John Darmawan

APLAR-COPCORD
Background and Policy Issues

The future of COPCORD
Arvind Chopra

12th APLAR Tentative Scientific Program
Thursday, 3rd August
Rooms MR 305
COPCORD Stage II Workshop: Stage II Treatment of Autoimmune Disease with Step-down Bridge Combination of Five Immunosuppressants 15.30-16.30
Chairpersons John Darmawan & Syed Atiqul Haq

Indonesia Experience in the Therapy of RA & NSAID-refractory Ankylosing Spondylitis
John Darmawan

Iran Experience in the Therapy of RA
Soosan Soorosh

China Experience in the Therapy of RA
Zhao Dongbao

Vietnam Experience in the Therapy of RA
Tran Thi Minh Hoa

12th APLAR Tentative Scientific Program
Friday, 4rd August
Rooms MR 306
COPCORD Stage II Workshop: Stage II Treatment of Autoimmune Disease with Step-down Bridge Combination of Five Immunosuppressants 15.30-16.30
Chairpersons John Darmawan & Syed Atiqul Haq

Indonesia Experience in the Therapy of Lupus Nephritis
John Darmawan

Iran Experience in the Therapy of NSAID-refractory Ankylosing Spondylitis
Soosan Soorosh

China Experience In the Therapy of Lupus Nephritis
Zhao Dongbao

Vietnam Experience in the Therapy Lupus Nephritis
Tran Thi Minh Hoa

Review of Biologic Response Modifiers
Efficacy, Adverse Effects, and safety in Various Autoimmune Diseases.
J J Rasker, The Netherlands

  Email This Page   Print This Page
 
NEWS & EVENTS

LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum

16.11.2005
MabThera – a unique approach providing lasting benefits for patients with rheumatoid arthritis

Comprehensive long-term clinical success achieved in difficult-to-treat patients following just two administrations, two weeks apart
 › more
 
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum

06.09.2005
Roche files first rheumatoid arthritis indication for MabThera in Europe

MabThera: a medicine used to treat non-Hodgkin's lymphoma

MabThera delivers significant and sustained relief from symptoms in patients with difficult-to-treat rheumatoid arthritis.
› more
 
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum

06.04.2005
MabThera significantly improves symptoms in patients with rheumatoid arthritis who inadequately responded to anti-TNFα therapies

Third large randomised trial to evaluate efficacy and safety of MabThera in RA

Roche, Genentech and Biogen Idec announced today that REFLEX1, a pivotal Phase III study of MabThera (rituximab), successfully met its primary endpoint in the group of patients with the most difficult-to-treat rheumatoid arthritis (RA).
 › more

Legal Disclamer

Legal Disclaimer

Copyright ©WHO-ILAR COPCORD Stage II Education on Treatment of the Autoimmune Diseases.

This Web site was developed in 2005 as a service provided by the WHO-ILAR COPCORD Stage II Education on Treatment of the Autoimmune Diseases. This Web site provides selected information available about lupus and arthritis. It is important that public see a healthcare professional for detailed information about medical conditions and treatment. This information is not intended to be a substitute for the advice of a healthcare professional, or a recommendation for any particular treatment plan. The WHO-ILAR COPCORD Stage II Education on Treatment of the Autoimmune Diseases has made and will continue to make efforts to include accurate and up-to-date information on this Web site.

If you have any questions, please contact us:
Webmaster
Phone: 62-24-8447-345
Fax: 62-24-8310-028
admin@LupusArthritisIndonesia.org
 


Supported by PT Roche Indonesia